Literature DB >> 18160514

Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfringens.

Fatemeh Rafii1, Miseon Park, Amy E Bryant, Shemedia J Johnson, Robert D Wagner.   

Abstract

Clostridium perfringens-induced gas gangrene is mediated by potent extracellular toxins, especially alpha toxin (a phospholipase C [PLC]) and theta toxin (perfringolysin O [PFO], a thiol-activated cytolysin); and antibiotic-induced suppression of toxin synthesis is an important clinical goal. The production of PLC and PFO by a gatifloxacin-induced, fluoroquinolone-resistant mutant strain of C. perfringens, strain 10G, carrying a stable mutation in DNA gyrase was compared with that of the wild-type (WT) parent strain. Zymography (with sheep red blood cell and egg yolk overlays) and time course analysis [with hydrolysis of egg yolk lecithin and O-(4 nitrophenyl-phosphoryl)choline] demonstrated that strain 10G produced more PLC and PFO than the WT strain. Increased toxin production in strain 10G was not related either to differences in growth characteristics between the wild-type and the mutant strain or to nonsynonymous polymorphisms in PLC, PFO, or their known regulatory proteins. Increased PLC and PFO production by strain 10G was associated with increased cytotoxic activity for HT-29 human adenocarcinoma cells and with increased platelet-neutrophil aggregate formation. Four other gatifloxacin-induced gyrase mutants did not show increased toxin production, suggesting that gatifloxacin resistance was not always associated with increased toxin production in all strains of C. perfringens. This is the first report of increased toxin production in a fluoroquinolone-resistant strain of C. perfringens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160514      PMCID: PMC2258526          DOI: 10.1128/AAC.01316-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  ELECTRON MICROSCOPE STUDY OF THE DEGRANULATION OF POLYMORPHONUCLEAR LEUKOCYTES FOLLOWING TREATMENT WITH STREPTOLYSIN.

Authors:  D ZUCKER-FRANKLIN
Journal:  Am J Pathol       Date:  1965-09       Impact factor: 4.307

2.  The Clostridium perfringens alpha-toxin.

Authors:  R W Titball; C E Naylor; A K Basak
Journal:  Anaerobe       Date:  1999-04       Impact factor: 3.331

3.  Phospholipase C assay using p-nitrophenylphosphoryl-choline together with sorbitol and its application to studying the metal and detergent requirement of the enzyme.

Authors:  S Kurioka; M Matsuda
Journal:  Anal Biochem       Date:  1976-09       Impact factor: 3.365

4.  Clostridial VirR/VirS regulon involves a regulatory RNA molecule for expression of toxins.

Authors:  Tohru Shimizu; Harumi Yaguchi; Kaori Ohtani; Sayera Banu; Hideo Hayashi
Journal:  Mol Microbiol       Date:  2002-01       Impact factor: 3.501

5.  Phenotypic characterization of enterotoxigenic Clostridium perfringens isolates from non-foodborne human gastrointestinal diseases.

Authors:  R E Collie; J F Kokai-Kun; B A McClane
Journal:  Anaerobe       Date:  1998-04       Impact factor: 3.331

6.  Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene.

Authors:  A E Bryant; R Y Chen; Y Nagata; Y Wang; C H Lee; S Finegold; P H Guth; D L Stevens
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

7.  Phylogenetic analysis of phospholipase C genes from Clostridium perfringens types A to E and Clostridium novyi.

Authors:  K Tsutsui; J Minami; O Matsushita; S Katayama; Y Taniguchi; S Nakamura; M Nishioka; A Okabe
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

8.  In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.

Authors:  David W Hecht; Minerva A Galang; Susan P Sambol; James R Osmolski; Stuart Johnson; Dale N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

9.  Lethal effects and cardiovascular effects of purified alpha- and theta-toxins from Clostridium perfringens.

Authors:  D L Stevens; B E Troyer; D T Merrick; J E Mitten; R D Olson
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

10.  Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein.

Authors:  A E Bryant; R Bergstrom; G A Zimmerman; J L Salyer; H R Hill; R K Tweten; H Sato; D L Stevens
Journal:  FEMS Immunol Med Microbiol       Date:  1993-12
View more
  4 in total

Review 1.  Listeriolysin O: A phagosome-specific cytolysin revisited.

Authors:  Brittney N Nguyen; Bret N Peterson; Daniel A Portnoy
Journal:  Cell Microbiol       Date:  2019-01-15       Impact factor: 3.715

2.  Global Phenotypic Characterization of Effects of Fluoroquinolone Resistance Selection on the Metabolic Activities and Drug Susceptibilities of Clostridium perfringens Strains.

Authors:  Miseon Park; Fatemeh Rafii
Journal:  Int J Microbiol       Date:  2014-12-21

3.  Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens.

Authors:  Sunny Park; Miseon Park; Fatemeh Rafii
Journal:  BMC Microbiol       Date:  2013-03-01       Impact factor: 3.605

4.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.